# VERIFY (NCT05210790)

> A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05210790
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Protagonist Therapeutics, Inc.
- Conditions: Polycythemia Vera
- Interventions: Placebo; Rusfertide
- Enrollment: 293
- Primary outcome: Proportion of subjects achieving a response who receive rusfertide compared to placebo.

## Commentary we found

- X threads: 5

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=verify-nct05210790